Filing metadata

Accession number
0001600620-25-000073
Form type
Form 3
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
May 16, 2025
Reporting period
May 15, 2025
Description
Initial ownership

Explore SEC Filings Hub